People: CorVel Corp (CRVL.O)
CRVL.O on Nasdaq
48.96USD
22 May 2013
48.96USD
22 May 2013
Price Change (% chg)
$-0.25 (-0.51%)
$-0.25 (-0.51%)
Prev Close
$49.21
$49.21
Open
$49.11
$49.11
Day's High
$49.93
$49.93
Day's Low
$48.83
$48.83
Volume
21,581
21,581
Avg. Vol
15,386
15,386
52-wk High
$51.36
$51.36
52-wk Low
$40.31
$40.31
Summary
| Name | Age | Since | Current Position |
|---|---|---|---|
V. Gordon Clemons |
68 | 2012 | Chairman of the Board, President, Chief Executive Officer, Chief Operating Officer |
Scott McCloud |
45 | 2005 | Chief Financial Officer |
Diane Blaha |
57 | 2010 | Senior Vice President - Sales and Account Management |
Donald McFarlane |
59 | 2007 | Chief Information Officer |
R. Judd Jessup |
64 | 1997 | Lead Independent Director |
Steven Hamerslag |
55 | 1991 | Independent Director |
Alan Hoops |
64 | 2003 | Independent Director |
Jean Macino |
69 | 2008 | Independent Director |
Jeffrey Michael |
55 | 1990 | Independent Director |
Biographies
| Name | Description |
|---|---|
V. Gordon Clemons |
Mr. V. Gordon Clemons, Sr., is Chairman of the Board, President, Chief Executive Officer, Chief Operating Officer of CorVel Corporation. Mr. Clemons has served as company's Chairman of the Board since April 1991. He was recently reappointed as company's Chief Executive Officer, President and Chief Operating Officer in April 2012 upon the resignation of Daniel Starck from those positions. He also served as company's Chief Executive Officer from January 1988 until August 2007, when Mr. Starck was appointed to that office, and as company's President from January 1988 until May 2006, when Mr. Starck was appointed to that office. Mr. Clemons was President of Caremark, Inc., a home intravenous therapy company, from May 1985 to September 1987, at which time Caremark was purchased by Baxter International, Inc. From 1981 to 1985, Mr. Clemons was President of INTRACORP, a medical management company and subsidiary of CIGNA Corporation. Mr. Clemons has 35 years of experience in the healthcare and insurance industries. |
Scott McCloud |
Mr. Scott F. McCloud is Chief Financial Officer of CorVel Corporaton since August 22, 2005. From June 1997 to August 2005, Mr. McCloud was company's Controller. Mr. McCloud joined CorVel in June 1995 and served as Assistant Controller until his promotion to Corporate Controller in June 1997. Prior to joining CorVel, Mr. McCloud served as a staff accountant at Geffen Mesher & Co., P.C. a public accounting firm, from 1994 to 1995. |
Diane Blaha |
Ms. Diane J. Blaha is Senior Vice President - Sales and Account Management of CorVel Corporation since November 2010. From November 2008 to November 2010, Ms. Blaha served as Vice President of Sales. From 1996 to November 2008, Ms. Blaha served as Vice President of Regional Sales. From 1994 to 1996, Ms. Blaha was an Account Executive in the Upper Midwest Region. Ms. Blaha joined CorVel in October 1992 as a Medical Case Manager until she moved into the sales and marketing team in 1994. |
Donald McFarlane |
Mr. Donald C. McFarlane is Chief Information Officer of CorVel Corporation since February 2007. Before becoming Chief Information Officer, Mr. McFarlane was Vice President, Information Technology from 1995 through January 2007. Prior to joining CorVel in 1994 as a Software Development Manager, Mr. McFarlane was Vice President of Avant Software, Inc., a software consulting company. In 1988, Avant was engaged to develop CorVel’s MedCheck medical bill review system, and Mr. McFarlane served as the chief architect and project manager for this effort. Mr. McFarlane has more than 36 years of experience in computer software and operations. |
R. Judd Jessup |
Mr. R. Judd Jessup is Lead Independent Director of CorVel Corporation since August 1997. Mr. Jessup has been Chief Executive Officer and a director of Combimatrix Corporation, a molecular diagnostics laboratory, from August 2010 to present. Mr. Jessup was Chief Executive Officer of U.S. LABS, a national laboratory which provides cancer diagnostic and genetic testing services, from 2002 to 2005. Mr. Jessup was President of the HMO Division of FHP International Corporation, a diversified health care services company, from 1994 to 1996. From 1987 to 1994, Mr. Jessup was President of TakeCare, Inc., a publicly held HMO operating in California, Colorado, Illinois and Ohio, until it was acquired by FHP. Mr. Jessup has 37 years of experience in the healthcare and managed care industries. Mr. Jessup has been a director of Superior Vision Services, a national managed vision care plan, since December 2007, a director of Accentcare since October 2005, a director of Xifin, Inc., a laboratory billing systems company, since January 2006, and a director of NovaMed, Inc. since August 1998. |
Steven Hamerslag |
Mr. Steven J. Hamerslag is Independent Director of CorVel Corporation since May 1991. Mr. Hamerslag has been Managing Partner of TVC Capital, a venture capital firm, since April 2006, and Managing Director of Titan Investment Partners, also a venture capital firm, since November 2002. Mr. Hamerslag served as the President and Chief Executive Officer of J2Global Communications, a publicly held unified communication services company, from June 1999 until January 2001. Mr. Hamerslag served as the CEO of MTI Technology Corporation, a publicly held manufacturer of enterprise storage solutions, from 1987 to 1996. |
Alan Hoops |
Mr. Alan R. Hoops is Independent Director of CorVel Corporation since May 2003. Mr. Hoops was Chairman of the Board and Chief Executive Officer of CareMore California Health Plan, a health maintenance organization, from March 2006 to August 2011. In August 2011, CareMore became a wholly-owned operating division of WellPoint, Inc. and Mr. Hoops remains Chief Executive Officer of CareMore until August 2012. Mr. Hoops has been Chairman of Benu, Inc., a regional benefits administration/marketing company since 2000. Mr. Hoops was Chairman of Enwisen, Inc., a human resources services software company, from 2001 to 2010 and Chief Executive Officer and a Director of Pacificare Health Systems, Inc., a national health consumer services company, from 1993 to 2000. Mr. Hoops has 39 years of experience in the healthcare and managed care industries. |
Jean Macino |
Ms. Jean H. Macino is Independent Director of CorVel Corporation since February 4, 2008. Ms. Macino was Managing Director of Marsh and McLennan Companies, an insurance broker and strategic risk advisor, from 1980 to 1995, and Office Head of the Newport Beach office of Marsh, Inc. from 1995 to 2005. Ms. Macino has served on the Board of Governors of Chapman University for the past ten years and currently serves as Chairman of the Governorship Committee of Chapman University. Ms. Macino has 36 years of experience in the insurance brokerage industry. |
Jeffrey Michael |
Mr. Jeffrey J. Michael is Independent Director of CorVel Corporation since September 1990. Mr. Michael has served as one of company's directors since September 1990. Mr. Michael has been President, Chief Executive Officer and a Director of Corstar Holdings, Inc., one of company's stockholders and a holding company owning equity interests in CorVel and an independent provider of data, voice, and video services to multiple dwelling units, since March 1996. |
Basic Compensation
| Name | Fiscal Year Total |
|---|---|
V. Gordon Clemons |
437,330 |
Scott McCloud |
288,918 |
Diane Blaha |
524,460 |
Donald McFarlane |
325,714 |
R. Judd Jessup |
-- |
Steven Hamerslag |
-- |
Alan Hoops |
-- |
Jean Macino |
-- |
Jeffrey Michael |
-- |
As Of 30 Mar 2012
Options Compensation
| Name | Options | Value |
|---|---|---|
V. Gordon Clemons |
76,250 | 867,150 |
Scott McCloud |
15,087 | 33,756 |
Diane Blaha |
3,000 | 74,706 |
Donald McFarlane |
5,075 | 96,004 |
R. Judd Jessup |
0 | 0 |
Steven Hamerslag |
0 | 0 |
Alan Hoops |
0 | 0 |
Jean Macino |
0 | 0 |
Jeffrey Michael |
0 | 0 |
| Name | Shares Traded | Price |
|---|---|---|
CLEMONS VICTOR GORDON |
200 | $50.00 |
HOOPS ALAN R |
5,625 | $20.83 |
MCFARLANE DONALD C |
244 | $25.82 |
MCFARLANE DONALD C |
244 | $50.00 |
CLEMONS VICTOR GORDON |
1,000 | $50.00 |
MCFARLANE DONALD C |
304 | $50.00 |
MCFARLANE DONALD C |
304 | $25.82 |
MCFARLANE DONALD C |
202 | $50.00 |
MCFARLANE DONALD C |
202 | $25.82 |
CLEMONS VICTOR GORDON |
501 | $50.00 |
BLAHA DIANE J |
102 | $47.02 |
MCCLOUD SCOTT R |
100 | $19.79 |
MCCLOUD SCOTT R |
100 | $32.44 |
MCCLOUD SCOTT R |
100 | $19.79 |
MCCLOUD SCOTT R |
100 | $25.82 |
MCCLOUD SCOTT R |
24 | $19.79 |
MCCLOUD SCOTT R |
3 | $47.90 |
MCCLOUD SCOTT R |
100 | $30.00 |
MCCLOUD SCOTT R |
50 | $47.46 |
MCCLOUD SCOTT R |
100 | $47.59 |
MCCLOUD SCOTT R |
99 | $47.51 |
MCCLOUD SCOTT R |
200 | $19.79 |
MCCLOUD SCOTT R |
100 | $47.64 |
MCCLOUD SCOTT R |
26 | $47.46 |
MCCLOUD SCOTT R |
100 | $19.79 |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
